MedTrace Logo

The Effect of Fecal Microbiota Transplantation in Ulcerative Colitis

NCT03711006 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2018-10-18

No results posted yet for this study

Summary

7 patients with active Ulcerative Colitis are treated with 25 multi-donor FMT Capsules daily for 50 days.

Conditions

Interventions

OTHER

Fecal Microbiota Transplantation Capsules

25 daily multi-donor FMT Capsules for 50 days

Sponsors & Collaborators

  • Alice Højer Christensen

    lead OTHER

Principal Investigators

  • Alice H Christensen, MD, PhD · Aleris-Hamlet Hospitals Copenhagen

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2017-11-30
Completion
2017-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03711006 on ClinicalTrials.gov